Other languages Merck & Co., Inc. Swiss Exchange

Equities

Delayed Swiss Exchange Other stock markets 11:36:38 2022-12-05 am EST			5-day change	1st Jan Change
400 ^CHF	+388.82%		-.--%	-.--%

Jul. 16	Merck: to present its advances in HIV at AIDS 24	CF
Jul. 16	Goldman Sachs Adjusts Price Target on Merck & Company to $145 From $144	MT

Merck : présentera ses avancées sur le VIH au congrès AIDS 24	Jul. 16
Novo owner backs Swiss biotech Asceneuron in $100 million round	Jul. 16
Sector Update: Health Care Stocks Mixed Premarket Friday	Jul. 12
Sector Update: Health Care	Jul. 12
Merck : finalise l'acquisition de EyeBio	Jul. 12
Merck Completes Eyebiotech Acquisition	Jul. 12
Immutep Achieves 'Positive' Results From Cohort B of Phase 2B Cancer Trial; Shares Rise Pre-Bell	Jul. 12
Merck & Co., Inc. completed the acquisition of Eyebiotech Limited.	Jul. 11
ETF de la semana: Consumo discrecional como tema a jugar	Jul. 09
Merck : achète la branche aquatique de Elanco Animal Health	Jul. 09
Merck's Animal Health Division Completes $1.3 Billion Acquisition of Elanco Animal Health's Aqua Business	Jul. 09
Prelude Therapeutics Inks Deal With Merck for Phase 2 Study to Evaluate its SMARCA2 Degrader With Keytruda	Jul. 09
ETF de la semana: Invertir en Europa fuera de Francia para evitar el riesgo político	Jul. 04
Stocks to watch as Biden and Trump vie for presidency	Jul. 03
MÄRKTE USA/Freundlich - Kräftige Gewinne bei Autoaktien	Jul. 02
MÄRKTE USA/Seitwärts in ruhigem Handel - Tesla auf Sechsmonatshoch	Jul. 02
MÄRKTE USA/Freundlich - Technologieaktien favorisiert	Jul. 01
MÄRKTE USA/Etwas fester - Marktzinsen steigen weiter	Jul. 01
Merck, Orion Convert Ongoing Collaboration Into Exclusive Global License for Opevesostat	Jul. 01
Merck : accord de licence avec Orion Corp. pour opevesostat	Jul. 01

No results for this search